Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Arteritis

• Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
• Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis
• A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
• Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
• Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
• Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission
• Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
• Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
• Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial
• Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement
• Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers
• A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
• A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis
• Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
• Abatacept for the Treatment of Giant Cell Arteritis
• Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
• Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
• Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA
• Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
• A Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (TAK)
• Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).
• MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
• Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
• KPL-301 for Subjects With Giant Cell Arteritis
• A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis
• Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
• Tocilizumab Plus a Short Prednisone Taper for GCA
• A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
• Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis
• Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
• Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
• Anti-inflammatory Treatment for Inactive Takayasu Arteritis
• Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
• Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a
• An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Cell Arteritis (GCA)
• A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
• Baricitinib in Relapsing Giant Cell Arteritis
• Takayasu Arteritis Clinical Trial in China
• Ustekinumab for the Treatment of Giant Cell Arteritis
• Giant Cell Arteritis and Anakinra Trial
• Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
• Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
• Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
• Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.
• An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)
• Tocilizumab for Patients With Giant Cell Arteritis
• Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
• Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
• Hydroxychloroquine in Giant Cell Arteritis
• HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
• Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
• Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis